Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 9(1): 17251, 2019 11 21.
Article in English | MEDLINE | ID: mdl-31754169

ABSTRACT

Acinetobacter baumannii is a feared, drug-resistant pathogen, characterized by its ability to resist extreme environmental and nutrient-deprived conditions. Previously, we showed that human serum albumin (HSA) can increase foreign DNA acquisition specifically and alter the expression of genes associated with pathogenicity. Moreover, in a recent genome-wide transcriptomic study, we observed that pleural fluid (PF), an HSA-containing fluid, increases DNA acquisition, can modulate cytotoxicity, and control immune responses by eliciting changes in the A. baumannii metabolic profile. In the present work, using more stringent criteria and focusing on the analysis of genes related to pathogenicity and response to stress, we analyzed our previous RNA-seq data and performed phenotypic assays to further explore the impact of PF on A. baumannii's microbial behavior and the strategies used to overcome environmental stress. We observed that PF triggered differential expression of genes associated with motility, efflux pumps, antimicrobial resistance, biofilm formation, two-component systems (TCSs), capsule synthesis, osmotic stress, and DNA-damage response, among other categories. Phenotypic assays of A. baumannii A118 and two other clinical A. baumannii strains, revealed differences in their responses to PF in motility, biofilm formation, antibiotic susceptibility, osmotic stress, and outer membrane vesicle (OMV) production, suggesting that these changes are strain specific. We conclude that A. baumannii's pathoadaptive responses is induced by HSA-containing fluids and must be part of this bacterium armamentarium to persist in hostile environments.


Subject(s)
Acinetobacter baumannii/drug effects , Acinetobacter baumannii/genetics , Pleura/metabolism , Acinetobacter baumannii/metabolism , Adaptation, Physiological/genetics , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Gene Expression Profiling/methods , Gene Expression Regulation, Bacterial/drug effects , Humans , Pleural Cavity , Stress, Physiological/genetics , Thoracentesis/methods , Transcriptome/drug effects
2.
Front Microbiol ; 10: 1581, 2019.
Article in English | MEDLINE | ID: mdl-31379769

ABSTRACT

Acinetobacter baumannii (Ab) is one of the most treacherous pathogens among those causing hospital-acquired pneumonia (HAP). A. baumannii possesses an adaptable physiology, seen not only in its antibiotic resistance and virulence phenotypes but also in its metabolic versatility. In this study, we observed that A. baumannii undergoes global transcriptional changes in response to human pleural fluid (PF), a key host-derived environmental signal. Differential gene expression analyses combined with experimental approaches revealed changes in A. baumannii metabolism, affecting cytotoxicity, persistence, bacterial killing, and chemotaxis. Over 1,220 genes representing 55% of the differentially expressed transcriptomic data corresponded to metabolic processes, including the upregulation of glutamate, short chain fatty acid, and styrene metabolism. We observed an upregulation by 1.83- and 2.61-fold of the pyruvate dehydrogenase complex subunits E3 and E2, respectively. We also found that pyruvate (PYR), in conjunction with PF, triggers an A. baumannii pathogenic behavior that adversely impacts human epithelial cell viability. Interestingly, PF also amplified A. baumannii cytotoxicity against murine macrophages, suggesting an immune evasion strategy implemented by A. baumannii. Moreover, we uncovered opposing metabolic strategies dependent on the degree of pathogenicity of the strains, where less pathogenic strains demonstrated greater utilization of PYR to promote persister formation in the presence of PF. Additionally, our transcriptomic analysis and growth studies of A. baumannii suggest the existence of an alternative phenylalanine (PA) catabolic route independent of the phenylacetic acid pathway, which converts PA to phenylpyruvate (PP) and shuttles intermediates into styrene metabolism. This alternative route promoted a neutrophil-evasive state, as PF-induced degradation of PP significantly reduced overall human neutrophil chemotaxis in ex vivo chemotactic assays. Taken together, these data highlight A. baumannii pathoadaptabililty in response to host signals and provide further insight into the role of bacterial metabolism in virulence traits, antibiotic persistence strategies, and host innate immune evasion.

3.
Diagn Microbiol Infect Dis ; 93(3): 183-187, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30420211

ABSTRACT

Transformation is one of the mechanisms of acquisition of foreign genetic material leading to the emergence of multidrug resistant (MDR) bacteria. Recently, human serum albumin (HSA) was shown to specifically increase transformation frequency in the nosocomial pathogen Acinetobacter baumannii. To further assess the relevance of HSA as a possible modulator of A. baumannii transformation in host-pathogen interactions, in this work we examined the effect of different human fluids. We observed a significant increase in transformation frequencies in the presence of pleural fluid, whole blood cells and liquid ascites, and to a lesser extent with urine. The observed effects correlate with both HSA and bacterial content found in the assayed patient fluids. Taken together, these results are in agreement with our previous findings that highlight HSA as a possible host signal with the ability to trigger natural transformation in A. baumannii.


Subject(s)
Acinetobacter baumannii/genetics , Body Fluids/physiology , Transformation, Bacterial/genetics , Acinetobacter Infections/microbiology , Body Fluids/chemistry , Body Fluids/microbiology , DNA/genetics , DNA Transformation Competence/genetics , Gene Expression , Gene Transfer, Horizontal/genetics , Genes, Bacterial/genetics , Humans , Serum Albumin, Human/analysis
4.
Sci Rep ; 8(1): 14741, 2018 10 03.
Article in English | MEDLINE | ID: mdl-30282985

ABSTRACT

In the past few decades Acinetobacter baumannii has emerged as a notorious nosocomial pathogen because of its ability to acquire genetic material and persist in extreme environments. Recently, human serum albumin (HSA) was shown to significantly increase natural transformation frequency in A. baumannii. This observation led us to perform transcriptomic analysis of strain A118 under HSA induction to identify genes that are altered by HSA. Our results revealed the statistically significant differential expression of 296 protein-coding genes, including those associated with motility, biofilm formation, metabolism, efflux pumps, capsule synthesis, and transcriptional regulation. Phenotypic analysis of these traits showed an increase in surface-associated motility, a decrease in biofilm formation, reduced activity of a citric acid cycle associated enzyme, and increased survival associated with zinc availability. Furthermore, the expression of genes known to play a role in pathogenicity and antibiotic resistance were altered. These genes included those associated with RND-type efflux pumps, the type VI secretion system, iron acquisition/metabolism, and ß-lactam resistance. Together, these results illustrate how human products, in particular HSA, may play a significant role in both survival and persistence of A. baumannii.


Subject(s)
Acinetobacter baumannii/drug effects , Gene Expression Regulation, Bacterial/drug effects , Genome, Bacterial , Serum Albumin, Human/pharmacology , beta-Lactam Resistance/drug effects , Acinetobacter baumannii/genetics , Acinetobacter baumannii/metabolism , Acinetobacter baumannii/pathogenicity , Bacterial Capsules/drug effects , Bacterial Capsules/genetics , Bacterial Capsules/metabolism , Biofilms , Citric Acid Cycle/drug effects , Citric Acid Cycle/genetics , Gene Expression Profiling , Genes, MDR/drug effects , Humans , Ion Transport/drug effects , Iron/metabolism , Microbial Viability/drug effects , Transformation, Bacterial/drug effects , Type VI Secretion Systems/genetics , Type VI Secretion Systems/metabolism , Zinc/metabolism , beta-Lactam Resistance/genetics , beta-Lactams/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL